MYC as a regulator of ribosome biogenesis and protein synthesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis. MYC coordinates protein synthesis through the transcriptional control of RNA and protein components of ribosomes, and of gene products required for the processing of ribosomal RNA, the nuclear export of ribosomal subunits and the initiation of mRNA translation. We discuss how the modulation of ribosome biogenesis by MYC may be essential to its physiological functions as well as its pathological role in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanical loading is also conveyed to the nucleolus through the transcription factor c-Myc”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“without sufficient induction of c-Myc, the expansion of translational capacity may be limited despite favorable metabolic conditions”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“Because this 45S transcript is rapidly processed and possesses a half-life measured in minutes, its abundance serves as an ultrasensitive, real-time indicator of active Pol I initiation and nucleolar stress [30,58].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 1×
“The deregulated expression of Myc proteins has been implicated in the development of a wide range of cancers (reviewed in Ref”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991 · cited 1×
“The translational machinery is composed of ribosome subunits, mRNA, transfer RNAs (tRNAs), and translation initiation and elongation factors (reviewed in Ref”
BackgroundGenomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Cited by
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
Ge, S. X., Son, E. W., & Yao, R. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2486-6 · Cited by 1,661
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 1,100
Johnson, N. A., Slack, G. W., Savage, K. J., Connors, J. M., Ben-Neriah, S., Rogic, S., Scott, D. W., Tan, K. L., Steidl, C., Sehn, L. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0985 · Cited by 975
Ribosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 818
Self-citationTargeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Ribosomal proteins: functions beyond the ribosome
Zhou, X., Liao, W.-J., Liao, J.-M., Liao, P., & Lu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv014 · Cited by 743
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Sebastián, C., Zwaans, B. M. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.047 · Cited by 660
“As a master regulator of cell proliferation, MYC regulates ribosome biogenesis and protein synthesis by controlling the transcription and assembly of ribosome components as well as translation initiation (Dang et al., 2012; van Riggelen et al., 2010).”
MYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
Bywater, M. J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C., Wall, M., Cluse, L., Drygin, D., Anderes, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.019 · Cited by 563
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
The genetics and mechanisms of T cell acute lymphoblastic leukaemia
Belver, L., & Ferrando, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.63 · Cited by 446
The genesis and evolution of high-grade serous ovarian cancer
Bowtell, D. D. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2946 · Cited by 445
ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
Hart, L. S., Cunningham, J. T., Datta, T., Dey, S., Tameire, F., Lehman, S. L., Qiu, B., Zhang, H., Cerniglia, G., Bi, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62973 · Cited by 433
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Kang, J., Brajanovski, N., Chan, K. T., Xuan, J., Pearson, R. B., & Sanij, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00728-8 · Cited by 408
Sun, T.-T., He, J., Liang, Q., Ren, L.-L., Yan, T.-T., Yu, T.-C., Tang, J.-Y., Bao, Y.-J., Hu, Y., Lin, Y., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0921 · Cited by 397
Lloyd, A. C. (2013) · Cell · doi:10.1016/j.cell.2013.08.053 · Cited by 393
“…in multiple tissues and organisms, and this is associated with increased ribosomal RNA (rRNA) levels, nucleolar size, increased protein biogenesis, and the metabolic reprogramming required for cell growth (Grewal et al., 2005; Saucedo and Edgar, 2002; van Riggelen et al., 2010; Wang et al., 2011).”
Functions of Ribosomal Proteins in Assembly of Eukaryotic Ribosomes In Vivo
de la Cruz, J., Karbstein, K., & Woolford, J. L. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033917 · Cited by 387
Translational Control in Cancer Etiology
Ruggero, D. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012336 · Cited by 367
Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
Trisomy 21 consistently activates the interferon response
Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., Smith, K. P., Liggett, L. A., Gomez, E. B., Galbraith, M. D., et al. (2016) · eLife · doi:10.7554/elife.16220 · Cited by 362
“On the other hand, the MYC family of transcription factors are known drivers of ribosome biogenesis, pro- tein synthesis and cell growth (van Riggelen et al., 2010; Boon et al., 2001; Kim et al., 2000; Arabi et al., 2005).”
BackgroundMYC and metabolism on the path to cancer
Hsieh, A. L., Walton, Z. E., Altman, B. J., Stine, Z. E., & Dang, C. V. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.08.003 · Cited by 332
Biomolecular Condensates and Cancer
Boija, A., Klein, I. A., & Young, R. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.003 · Cited by 327
Luo, W., Weisel, F., & Shlomchik, M. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.008 · Cited by 325
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A., & Samant, R. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4087 · Cited by 300
Ribosome biogenesis in disease: new players and therapeutic targets
Jiao, L., Liu, Y., Yu, X.-Y., Pan, X., Zhang, Y., Tu, J., Song, Y.-H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01285-4 · Cited by 313
Sun, L., Song, L., Wan, Q., Wu, G., Li, X., Wang, Y., Wang, J., Liu, Z., Zhong, X., He, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.33 · Cited by 310
Translational Control in Cancer
Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032896 · Cited by 302
Koh, C. M., Bieberich, C. J., Dang, C. V., Nelson, W. G., Yegnasubramanian, S., & De Marzo, A. M. (2010) · Genes & Cancer · doi:10.1177/1947601910379132 · Cited by 296
den Boon, J. A., Pyeon, D., Wang, S. S., Horswill, M., Schiffman, M., Sherman, M., Zuna, R. E., Wang, Z., Hewitt, S. M., Pearson, R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509322112 · Cited by 291
The Circadian Clock Coordinates Ribosome Biogenesis
Jouffe, C., Cretenet, G., Symul, L., Martin, E., Atger, F., Naef, F., & Gachon, F. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001455 · Cited by 292
SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease
Shin, J., He, M., Liu, Y., Paredes, S., Villanova, L., Brown, K., Qiu, X., Nabavi, N., Mohrin, M., Wojnoonski, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.007 · Cited by 287
“Chromatin remodeling is believed to be central to Myc function in modulating the expression of its target genes (Knoepfler et al., 2006; van Riggelen et al., 2010).”
BackgroundPourdehnad, M., Truitt, M. L., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 286
Nucleolar stress with and without p53
James, A., Wang, Y., Raje, H., Rosby, R., & DiMario, P. (2014) · Nucleus · doi:10.4161/nucl.32235 · Cited by 285
Nucleolar Stress: hallmarks, sensing mechanism and diseases
Yang, K., Yang, J., & Yi, J. (2018) · Cell Stress · doi:10.15698/cst2018.06.139 · Cited by 283
Gee, H. E., Buffa, F. M., Camps, C., Ramachandran, A., Leek, R., Taylor, M., Patil, M., Sheldon, H., Betts, G., Homer, J., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606076 · Cited by 283
Donati, G., Peddigari, S., Mercer, C. A., & Thomas, G. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.045 · Cited by 262
Emerging roles of aerobic glycolysis in breast cancer
Wu, Z., Wu, J., Zhao, Q., Fu, S., & Jin, J. (2020) · Clinical and Translational Oncology · doi:10.1007/s12094-019-02187-8 · Cited by 255
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
Sanchez-Martin, M., & Ferrando, A. (2017) · Blood · doi:10.1182/blood-2016-09-692582 · Cited by 256
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Duy, C., Li, M., Teater, M., Meydan, C., Garrett-Bakelman, F. E., Lee, T. C., Chin, C. R., Durmaz, C., Kawabata, K. C., Dhimolea, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1375 · Cited by 253
The nucleolus: an emerging target for cancer therapy
Hein, N., Hannan, K. M., George, A. J., Sanij, E., & Hannan, R. D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.005 · Cited by 246
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Chen, B.-J., Wu, Y.-L., Tanaka, Y., & Zhang, W. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.10190 · Cited by 248
p53 and ribosome biogenesis stress: The essentials
Golomb, L., Volarevic, S., & Oren, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.014 · Cited by 242
The Ribosome Biogenesis—Cancer Connection
Penzo, M., Montanaro, L., Treré, D., & Derenzini, M. (2019) · Cells · doi:10.3390/cells8010055 · Cited by 242
MYC and tumor metabolism: chicken and egg
Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240
“In addition to enhancing the uptake of nutrients, MYC sustains the function of mTORC1 also by driving the synthesis of macromolecules, like translation factors and ribosomal components, necessary for protein biosynthesis (Lin et al, 2008; van Riggelen et al, 2010; Pourdehnad et al, 2013).”
BackgroundInitial Quantitative Proteomic Map of 28 Mouse Tissues Using the SILAC Mouse
Geiger, T., Velic, A., Macek, B., Lundberg, E., Kampf, C., Nagaraj, N., Uhlen, M., Cox, J., & Mann, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024919 · Cited by 235
Targeting the nucleolus for cancer intervention
Quin, J. E., Devlin, J. R., Cameron, D., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.009 · Cited by 226
Zhang, D., Park, D., Zhong, Y., Lu, Y., Rycaj, K., Gong, S., Chen, X., Liu, X., Chao, H.-P., Whitney, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms10798 · Cited by 227
Wang, W., Nag, S., Zhang, X., Wang, M., Wang, H., Zhou, J., & Zhang, R. (2015) · Medicinal Research Reviews · doi:10.1002/med.21327 · Cited by 224
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
Sun, X.-X., He, X., Yin, L., Komada, M., Sears, R. C., & Dai, M.-S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411713112 · Cited by 221
Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis
Buszczak, M., Signer, R. A. J., & Morrison, S. J. (2014) · Cell · doi:10.1016/j.cell.2014.09.016 · Cited by 220
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
Turi, Z., Lacey, M., Mistrik, M., & Moudry, P. (2019) · Aging · doi:10.18632/aging.101922 · Cited by 215
Ribosome biogenesis: Emerging evidence for a central role in the regulation of skeletal muscle mass
Chaillou, T., Kirby, T. J., & McCarthy, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24604 · Cited by 211
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Liu, P. Y., Xu, N., Malyukova, A., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S.-P., Nelson, C., Chang, D. K., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.147 · Cited by 207
Yue, M., Jiang, J., Gao, P., Liu, H., & Qing, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.002 · Cited by 202
Goetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
Translational control of stem cell function
Saba, J. A., Liakath-Ali, K., Green, R., & Watt, F. M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00386-2 · Cited by 194
The Dynamic Regulatory Genome of Capsaspora and the Origin of Animal Multicellularity
Sebé-Pedrós, A., Ballaré, C., Parra-Acero, H., Chiva, C., Tena, J. J., Sabidó, E., Gómez-Skarmeta, J. L., Di Croce, L., & Ruiz-Trillo, I. (2016) · Cell · doi:10.1016/j.cell.2016.03.034 · Cited by 188
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia
Zhou, F., Liu, Y., Rohde, C., Pauli, C., Gerloff, D., Köhn, M., Misiak, D., Bäumer, N., Cui, C., Göllner, S., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3563 · Cited by 187
Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age
Ferreira, R., Schneekloth, J. S., Panov, K. I., Hannan, K. M., & Hannan, R. D. (2020) · Cells · doi:10.3390/cells9020266 · Cited by 183
The Transcription Factor FOXM1 (Forkhead box M1)
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 176
Gutierrez-Arcelus, M., Teslovich, N., Mola, A. R., Polidoro, R. B., Nathan, A., Kim, H., Hannes, S., Slowikowski, K., Watts, G. F. M., Korsunsky, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08604-4 · Cited by 176
Ribosome Biogenesis and Control of Cell Proliferation: p53 Is Not Alone
Donati, G., Montanaro, L., & Derenzini, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3992 · Cited by 175
The small subunit processome in ribosome biogenesis—progress and prospects
Phipps, K. R., Charette, J. M., & Baserga, S. J. (2011) · WIREs RNA · doi:10.1002/wrna.57 · Cited by 175
Zhang, W., Liu, Y., Yan, Z., Yang, H., Sun, W., Yao, Y., Chen, Y., & Jiang, R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000285 · Cited by 173
Dong, H., Adams, N. M., Xu, Y., Cao, J., Allan, D. S. J., Carlyle, J. R., Chen, X., Sun, J. C., & Glimcher, L. H. (2019) · Nature Immunology · doi:10.1038/s41590-019-0388-z · Cited by 172
Molecular Mechanisms of Skeletal Muscle Hypertrophy
Schiaffino, S., Reggiani, C., Akimoto, T., & Blaauw, B. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200568 · Cited by 157
Birket, M. J., Orr, A. L., Gerencser, A. A., Madden, D. T., Vitelli, C., Swistowski, A., Brand, M. D., & Zeng, X. (2011) · Journal of Cell Science · doi:10.1242/jcs.072272 · Cited by 169
Development of a stress response therapy targeting aggressive prostate cancer
Nguyen, H. G., Conn, C. S., Kye, Y., Xue, L., Forester, C. M., Cowan, J. E., Hsieh, A. C., Cunningham, J. T., Truillet, C., Tameire, F., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2036 · Cited by 167
The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
Orsolic, I., Jurada, D., Pullen, N., Oren, M., Eliopoulos, A. G., & Volarevic, S. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.004 · Cited by 168
Nishimura, K., Kumazawa, T., Kuroda, T., Katagiri, N., Tsuchiya, M., Goto, N., Furumai, R., Murayama, A., Yanagisawa, J., & Kimura, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.055 · Cited by 163
Ji, H., Wu, G., Zhan, X., Nolan, A., Koh, C., De Marzo, A., Doan, H. M., Fan, J., Cheadle, C., Fallahi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026057 · Cited by 164
Tang, W., Zhou, M., Dorsey, T. H., Prieto, D. A., Wang, X. W., Ruppin, E., Veenstra, T. D., & Ambs, S. (2018) · Genome Medicine · doi:10.1186/s13073-018-0602-x · Cited by 162
“gene as a regulator of ribosome biogenesis and enhancer of protein synthesis [29, 30] and the proteogenomic”
Qiu, X., Boufaied, N., Hallal, T., Feit, A., de Polo, A., Luoma, A. M., Alahmadi, W., Larocque, J., Zadra, G., Xie, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30257-z · Cited by 159
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Mi, W., Guan, H., Lyu, J., Zhao, D., Xi, Y., Jiang, S., Andrews, F. H., Wang, X., Gagea, M., Wen, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01173-4 · Cited by 159
“(47) (48) Ribosome DNA replication Cell cycle Mismatch repair Spliceosome Lysosome Other glycan degradation Glycosaminoglycan degradation ECM-receptor interaction Focal adhesion”
BackgroundActivation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Bursać, S., Brdovčak, M. C., Donati, G., & Volarević, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.014 · Cited by 180
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Johansson, P. A., Brooks, K., Newell, F., Palmer, J. M., Wilmott, J. S., Pritchard, A. L., Broit, N., Wood, S., Carlino, M. S., Leonard, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16276-8 · Cited by 153
Bossen, C., Murre, C. S., Chang, A. N., Mansson, R., Rodewald, H.-R., & Murre, C. (2015) · Nature Immunology · doi:10.1038/ni.3170 · Cited by 151
Key contribution of CPEB4-mediated translational control to cancer progression
Zapater, E. O., Pineda, D., Martínez‐Bosch, N., Fernández‐Miranda, G., Iglesias, M., Alameda, F., Moreno, M., Eliscovich, C., Eyras, E., Real, F. X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2540 · Cited by 160
Kang, J., Sergio, C. M., Sutherland, R. L., & Musgrove, E. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-32 · Cited by 152
McMahon, M., Contreras, A., & Ruggero, D. (2015) · WIREs RNA · doi:10.1002/wrna.1266 · Cited by 147
Genome-wide Association of Yorkie with Chromatin and Chromatin-Remodeling Complexes
Oh, H., Slattery, M., Ma, L., Crofts, A., White, K. P., Mann, R. S., & Irvine, K. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.008 · Cited by 145
“Indeed, the crucial role of Myc in promoting growth is thought to stem in part from its role in promoting the expression of ribosomal proteins (van Riggelen et al., 2010), and thereby increasing cellular mass through a global increase in cellular translation.”
Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 143
Gene Expression Profiling Predicts the Development of Oral Cancer
Saintigny, P., Zhang, L., Fan, Y.-H., El‐Naggar, A. K., Papadimitrakopoulou, V. A., Feng, L., Lee, J. J., Kim, E. S., Hong, W. K., & Mao, L. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0155 · Cited by 162
Lee, B.-K., Bhinge, A. A., Battenhouse, A., McDaniell, R. M., Liu, Z., Song, L., Ni, Y., Birney, E., Lieb, J. D., Furey, T. S., et al. (2012) · Genome Research · doi:10.1101/gr.127597.111 · Cited by 142
The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes
Raza, A., & Galili, N. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3321 · Cited by 170
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer
Lancho, O., & Herranz, D. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.10.003 · Cited by 141
Riemondy, K. A., Venkataraman, S., Willard, N., Nellan, A., Sanford, B. L., Griesinger, A. M., Amani, V. M., Mitra, S. S., Hankinson, T. C., Handler, M. H., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noab135 · Cited by 171
Cao, W., Lee, H., Wu, W., Zaman, A., McCorkle, S., Yan, M., Chen, J., Xing, Q., Sinnott-Armstrong, N., Xu, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17227-z · Cited by 148
Atlas of Genetics and Cytogenetics in Oncology and Haematology
(2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/15655 · Cited by 139
Dysregulation of RNA polymerase I transcription during disease
Hannan, K. M., Sanij, E., Rothblum, L. I., Hannan, R. D., & Pearson, R. B. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.10.014 · Cited by 137
Ishizawa, J., Kojima, K., Hail, N., Tabe, Y., & Andreeff, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.001 · Cited by 142
Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
Golomb, L., Bublik, D. R., Wilder, S., Nevo, R., Kiss, V., Grabusic, K., Volarevic, S., & Oren, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.022 · Cited by 137
“Its role in regulating the transcription of genes encoding RPs and other accessory factors of the ribosome biogenesis machinery is also well established (van Riggelen et al., 2010).”
Widespread Translational Remodeling during Human Neuronal Differentiation
Blair, J. D., Hockemeyer, D., Doudna, J. A., Bateup, H. S., & Floor, S. N. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.095 · Cited by 135
Tomecki, R., Sikorski, P. J., & Zakrzewska‐Placzek, M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12682 · Cited by 142
Metadata
- Authors
- van Riggelen, J., Yetil, A., & Felsher, D. W.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Felsher, Dean W.
- ORCID
- Felsher, Dean W.
- Venue
- Nature Reviews Cancer
- Published
- 2010-04
- Volume
- 10
- Issue
- 4
- Pages
- 301-309
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2021764678
- Cited by
- 956
- References
- 126
- Citations by year
- 2026: 59 · 2025: 65 · 2024: 94 · 2023: 72 · 2022: 61 · 2021: 68 · 2020: 75 · 2019: 63 · 2018: 50 · 2017: 57 · 2016: 48 · 2015: 57 · 2014: 53 · 2013: 43 · 2012: 39
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Leukemia and Lymphoma Society
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, ribosome biogenesis, protein synthesis, rRNA processing, translation initiation, transcriptional regulation, carcinogenesis, cell proliferation
- MeSH terms
- Gene Expression Regulation, Homeostasis, Humans, Models, Genetic, Neoplasms, Ribosomal Proteins, Ribosomes, RNA, Messenger, Protein Biosynthesis, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.